Tools / Earnings

Earnings calendar

76 earnings reports from 49 healthcare companies. When they report, the one number that will move the story, and what it means for you.

4 days untilCigna Group and HumanaNov 5, 2026 5 days untilHumanaHUMNov 6, 2026 5 days untilHumanaHUMNov 6, 2026

Make it about you I work in

Most-covered companies

Only upcoming ★ My watchlist 📅 Subscribe to all dates

Humana Nov 6, 2026 · First earnings call since the CenterWell clinic recapitalization with BlackRock was announced; Elevance Health also reports October 21 from an 89.7% Q2 benefit expense ratio, and HCA Healthcare reports October 27

Humana Nov 6, 2026 · 2026 adjusted EPS of at least $9.00 and any change to GAAP guidance

Cigna Group and Humana Nov 5, 2026 · Humana insurance benefit ratio vs 92.75% plus or minus 25 bps guide

Tenet Healthcare Oct 29, 2026 · 2026 adjusted EBITDA guidance of $4.83 billion to $5.03 billion

Tenet Healthcare Oct 29, 2026 · Revenue per adjusted admission up 0.2% against adjusted EBITDA up 23.3%; $147M of the quarter was timing and transition benefits

DaVita Oct 29, 2026 · U.S. revenue per treatment $415.25 vs patient care cost $280.22

Alignment Healthcare Oct 29, 2026 · Medical benefits ratio of 89.5% and full-year adjusted EBITDA guidance of at least $100 million

CareDx Oct 29, 2026 · 2026 revenue guidance of $520 million to $530 million and adjusted EBITDA guidance of $90 million to $100 million

Healthcare Realty Trust Oct 29, 2026 · 2026 same-store cash NOI growth guidance of 5.00% to 5.25%; normalized FFO guidance of $1.65 to $1.67 per share

Tenet Healthcare (USPI) Oct 29, 2026 · USPI same-facility cases down 1.5%, net revenue per case up 6.1%

Community Health Systems Oct 28, 2026 · Adjusted EBITDA down 25.5% to $280M, a 10.2% margin; 59 hospitals versus 70 a year earlier

Encompass Health Oct 28, 2026 · Revenue per discharge $22,543, up 4.0%

Teladoc Health Oct 28, 2026 · BetterHelp revenue $206.6M, down 13%; convertible notes $997.6M now current

Universal Health Services Oct 28, 2026 · Adjusted EBITDA net of noncontrolling interests of $624.6 million, below expectations

HCA Healthcare Oct 27, 2026 · Uninsured volume and payer mix shift, roughly $400 million pretax impact in the quarter

Centene Oct 27, 2026 · 2027 Marketplace enrollment and guidance (none given in the release)

Universal Health Services Oct 27, 2026 · Acute care revenue per adjusted admission, down 1.7%

Chemed Corporation (VITAS) Oct 27, 2026 · Hospice average daily census growth of 9.4 percent and Medicare cap accrual of $828,000 versus $6.1 million a year earlier

HCA Healthcare Oct 27, 2026 · ASC volumes down 5.4%, total surgical volume down 1.4%

Quest Diagnostics Oct 22, 2026 · Requisition volume up 14.5% against revenue per requisition down 4.2%, and full-year adjusted EPS guidance of $11.25 to $11.35

Elevance Health Oct 21, 2026 · Benefit expense ratio, which was 89.7% in Q2, up 80 basis points from 88.9%

Elevance Health Oct 21, 2026 · Benefit expense ratio of 90.6% versus 91.3%, with full-year adjusted EPS guidance of at least $29.00

Molina Healthcare Oct 21, 2026 · Consolidated medical care ratio of 92.9%, with segment ratios of 93.0% Medicaid, 93.0% Medicare and 92.5% Marketplace

Intuitive Surgical Oct 20, 2026 · $450 million antitrust settlement charge, GAAP EPS of $1.49 against $3.00 non-GAAP, and 2026 da Vinci procedure growth guidance of about 14% to 15%

Johnson & Johnson Oct 14, 2026 · MedTech growth of 2.5% to $8.6 billion; U.S. MedTech up 4.8% and outside the U.S. up 0.1%

Johnson & Johnson Oct 14, 2026 · Reported EPS of $0.09 vs $2.12 and adjusted EPS of $2.59 vs $2.80; 2026 adjusted EPS guidance raised to $11.05 to $11.15

UnitedHealth Group Oct 13, 2026 · medical care ratio and Medicare Advantage membership

UnitedHealth Group Oct 13, 2026 · Medical care ratio of 88.4% including $610 million of favorable reserve development

UnitedHealth Group Oct 13, 2026 · Optum home health visits up 10% year over year; Optum Health revenue down 10% to $22.9B; operating earnings $735M

UnitedHealth Group Oct 13, 2026 · Optum Health earnings from operations of $735 million on revenue of $22.9 billion (3.2 percent margin)

Oscar Health Sep 16, 2026 · Medical loss ratio guidance 81.0 to 82.0 percent (50 basis point improvement); earnings from operations guidance $600 million to $800 million (up $100 million at midpoint); full-year revenue guidance $18.7 to $19.0 billion

Ascension Sep 16, 2026 · Fiscal 2026 net income 1.5 billion dollars; operating loss narrowed to 120 million dollars from 491 million dollars; recurring operating EBITDA 1.2 billion dollars

LifeStance Health Group Sep 15, 2026 · Q2 revenue +26% year over year; adjusted EBITDA +94% year over year; full-year guidance raised $70 million cumulatively; targeting mid-teens adjusted EBITDA margin by 2028

UnitedHealth Group Sep 9, 2026 · MA margins tracking upper half of 2 to 4 percent target range; enrollment at approximately 7.6 million, down from 8.4 million at end of 2025; potential 34-county exit affecting roughly 20,000 additional members; 2027 bid pricing competitiveness

Medtronic Sep 1, 2026 · Raised fiscal 2027 non-GAAP diluted EPS guidance of $5.94 to $6.00

RadNet Inc. Aug 10, 2026 · AI-specific revenue up 136% year over year; AI annual recurring revenue nearly doubled to $105.5 million

Definitive Healthcare Aug 10, 2026 · Turbo AI platform adoption and customer retention as revenue stabilizers

Surgery Partners Aug 10, 2026 · Full-year revenue guidance of $3.35B to $3.45B; whether additional acquisitions close before year-end after management walked back the $200M annual M&A target

Surgery Partners Aug 10, 2026 · $5,057 net revenue per surgical case, up 5.8% year over year; same-facility revenue growth of 5% driven by case mix and pricing, not volume growth

Clover Health Aug 6, 2026 · Medicare Advantage membership, 157,309, up 48 percent year over year

Oscar Health Aug 6, 2026 · implied second-half operating loss of roughly 393 million to 593 million dollars

Privia Health Aug 6, 2026 · implemented providers, 5,644, and value-based care attributed lives, 1.647 million

Doximity, Inc. Aug 6, 2026 · AI Search revenue recognition in coming quarters

GoodRx, Inc. Aug 6, 2026 · Pharma Direct revenue growth rate versus legacy prescription transaction decline

AMN Healthcare Services Aug 6, 2026 · Q3 2026 revenue guidance of 640 to 655 million dollars

American Healthcare REIT Aug 6, 2026 · $1.4 billion in new investments completed since the start of 2026, with more than $800 million more in the pipeline; raised FY2026 guidance to $2.15 to $2.19 normalized FFO per diluted share

CVS Health Aug 5, 2026 · Full year 2026 adjusted EPS guidance raised to 7.90 to 8.10 dollars

Eli Lilly Aug 5, 2026 · Full year 2026 revenue guidance raised to 85 to 87 billion dollars, the second raise this year

agilon health Aug 5, 2026 · Full-year 2026 revenue guidance raised to 5.775 to 5.86 billion dollars

CVS Health Aug 5, 2026 · Adjusted EPS rose 42.5 percent to $2.58 and revenue climbed 7.3 percent to $106.1 billion; full year adjusted profit guidance raised to $7.90 to $8.10 per share, but shares fell about 9 percent

Pfizer Aug 4, 2026 · Full year 2026 revenue guidance raised to $60.5 billion to $62.5 billion

Novo Nordisk Aug 4, 2026 · Oral Wegovy pill sales of 3.22 billion Danish kroner versus about 3.27 billion kroner expected

Hinge Health Aug 4, 2026 · Full year 2026 revenue guidance raised to $856-860 million

DaVita Aug 4, 2026 · Integrated Kidney Care adjusted operating income $40 million vs $19 million Q1 loss; 64,900 value-based patients, $5.8 billion annualized medical spend under management

The Cigna Group Jul 30, 2026 · Medical care ratio rose to 84.5 percent

Bristol Myers Squibb Jul 30, 2026 · Growth Portfolio revenue (Opdivo Qvantig, Reblozyl, Camzyos, Breyanzi, Opdualag), up 15% to 7.6 billion dollars and now nearly 60% of total revenue

Regeneron Pharmaceuticals Jul 30, 2026 · Whether the Q3 step-up in Sanofi collaboration profit, now that the Development Balance is fully repaid, shows up in guidance.

Alignment Healthcare Jul 30, 2026 · Adjusted medical benefit ratio improved to 86.3%, the lowest since the company went public, while full-year 2026 membership guidance was raised to 298,000-301,000

Healthcare Realty Trust Jul 30, 2026 · Full-year 2026 same-store cash NOI growth guidance raised to a range of 4.25% to 5%, alongside a redevelopment pipeline expanding to roughly 30 assets by year end

Boston Scientific Corporation Jul 29, 2026 · $5.442B net sales (+7.5%); FY adjusted EPS guidance $3.28-$3.32 vs $3.36 consensus

Humana Inc. Jul 29, 2026 · Benefit ratio rose to 91.2% from 89.9%; GAAP EPS guidance floor cut to at least $6.52 from at least $8.36

Ventas, Inc. Jul 29, 2026 · Full year 2026 senior housing investment target raised to more than 4.5 billion dollars, up from 3 billion dollars

Centene Corporation Jul 28, 2026 · Marketplace enrollment under the Ambetter brand, which fell to 3.5 million from 5.8 million a year ago

Grifols, S.A. Jul 28, 2026 · 29 US plasma donor center closures amid a July 1, 2026 reorganization separating US and global plasma operations

Universal Health Services Jul 27, 2026 · Full year adjusted diluted EPS guidance of 22.28 to 23.65 dollars

Community Health Systems Jul 23, 2026 · Full-year 2026 guidance of a diluted loss per share of 1.10 to 1.25 dollars

Molina Healthcare Jul 23, 2026 · Full-year 2026 revenue guidance held near 42 billion dollars, about 2.28 billion dollars below analyst expectations of roughly 44.28 billion dollars

HCA Healthcare Jul 23, 2026 · ~400 million dollar ACA coverage-loss hit nearly offset by ~400 million dollar Florida Medicaid Supplemental Payment Program benefit

Quest Diagnostics Jul 23, 2026 · Adjusted EPS growth of 19.1% to 3.12 dollars; FY2026 revenue guidance raised to 11.95-12.05 billion dollars

Tenet Healthcare Jul 23, 2026 · Adjusted EPS 6.12 dollars vs 4.26 dollar consensus; FY2026 EPS guidance raised to 20.30-21.69 dollars

Gentherm Incorporated Jul 23, 2026 · 400 million dollar stock buyback authorization and the roughly 1 billion dollar Modine Performance Technologies combination closing

Intuitive Surgical Jul 19, 2026 · US da Vinci procedure growth rate against full-year guidance of 13.5 to 15.5 percent

Johnson & Johnson Jul 16, 2026 · J&J raised full-year 2026 guidance to about $101.1 billion in sales, on pace to top $100 billion for the first time; Abbott also beat estimates, raising full-year adjusted EPS guidance to $5.45-$5.60

UnitedHealth Group Jul 16, 2026 · Medical care ratio fell to 86.7% of premiums from 89.4% a year earlier; full-year adjusted EPS guidance raised to $19.50-$20.00

Elevance Health Jul 15, 2026 · Medical loss ratio rose 80 basis points to 89.7%; medical membership fell to about 44.9 million, down 469,000 from the prior quarter

HCA Healthcare Jul 15, 2026 · Full-year 2026 ACA exchange hit now estimated at $1.0 billion to $1.2 billion, up from a prior $600 million to $900 million estimate